Tien Liang BioTech Co., Ltd. (4127.TWO)

TWD 40.9

(0.25%)

Market Cap (In TWD)

1.87 Billion

Revenue (In TWD)

459.99 Million

Net Income (In TWD)

17.73 Million

Avg. Volume

466.27 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
13.9-47.8
PE
-
EPS
-
Beta Value
0.559
ISIN
TW0004127006
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Min-Chung Chi
Employee Count
-
Website
https://www.tlb.com.tw
Ipo Date
2007-12-31
Details
Tien Liang BioTech Co., Ltd. manufactures and sells pharmaceutical products in Taiwan and internationally. The company offers Chinese medicine products, such as pills for liver and kidney deficiency, low back pain, sore feet, dizziness, thirst, dry tongue, sore throat, and heel pain, as well as rheumatism, joint pain, traveling pain, wind-cold-dampness, gout, neuralgia, enuresis, hemorrhoids, constipation, athlete's foot, fall injuries, cold, bronchitis, cough, and phlegm indications. It provides western medicine products, including ointment, hair removal cream, tablet, capsule, soreness spray, and pain patch products, as well as pain relief gels. In addition, the company offers healthcare products; and other products for body relaxation and comfort, and relieving discomfort after exercise, as well as tooth products and soaps. The company was founded in 1960 and is based in New Taipei City, Taiwan.